“…Structurally, the active form of DLDH is a stable homodimer, with each monomer possessing a non-covalently but tightly bound FAD molecule, a transiently bound NAD + or NADH molecule, and a redox active center containing two cysteine residues (Cys-45 and Cys-50 in both human and rat) that are directly engaged in thiol-disulfide exchange reactions during catalysis (Brautigam, et al, 2005, Ciszak, et al, 2006, Thorpe and Williams, 1976, Williams, 1992. In vivo, DLDH oxidizes dihydrolipoamide that is covalently linked to acyltransferase using NAD + as the electron acceptor, leading to the release of NADH (Patel and Roche, 1990, Vettakkorumakankav and Patel, 1996, Williams, 1992. This reaction is usually referred to as the forward reaction of DLDH, as opposed to the reverse reaction, in which DLDH catalyzes the oxidation of NADH using lipoamide as the electron acceptor.…”